Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sanjay Lalwani, Sukanta Chatterjee, Jugesh Chhatwal, Valsan P. Verghese, Shailesh Mehta, Fakrudeen Shafi, Dorota Borys, Marta Moreira & Lode Schuerman. (2012) Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled study. Human Vaccines & Immunotherapeutics 8:5, pages 612-622.
Read now
Read now
Articles from other publishers (7)
Daniel D’Agostino, Maria Camila Sanchez & Gustavo Boldrini. 2019. Pediatric Hepatology and Liver Transplantation. Pediatric Hepatology and Liver Transplantation
687
698
.
Khalequ Zaman, Sheikh Farzana Zaman, Farzana Zaman, Asma Aziz, Sayeed-Bin Faisal, Magali Traskine, Md Ahsan Habib, Javier Ruiz-Guiñazú & Dorota Borys. (2018) Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study. Vaccine 36:5, pages 698-706.
Crossref
Crossref
. (2012) A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants. New England Journal of Medicine 367:24, pages 2284-2295.
Crossref
Crossref
Nancy Bermal, Leszek Szenborn, Edison Alberto, Marina Hernandez, Jerzy Pejcz, Ewa Majda-Stanislawska, Salvacion Gatchalian, Aurélie Fanic, Ilse Dieussaert & Lode Schuerman. (2011) SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE COADMINISTERED WITH DTPW-HBV/HIB AND POLIOVIRUS VACCINES. Pediatric Infectious Disease Journal 30:1, pages 69-72.
Crossref
Crossref
Sukanta Chatterjee, Sylvan J Rego, Fulton D'Souza, BD Bhatia, Alix Collard, Sanjoy K Datta & Jeanne-Marie Jacquet. (2010) The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule. BMC Infectious Diseases 10:1.
Crossref
Crossref
Felix Espinoza, Miguel Tregnaghi, Angela Gentile, Katia Abarca, Javier Casellas, Alix Collard, Inge Lefevre & Jeanne-Marie Jacquet. (2010) Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial. BMC Infectious Diseases 10:1.
Crossref
Crossref
Nancy Bermal, Leszek Szenborn, Andrzej Chrobot, Edison Alberto, Patricia Lommel, Salvacion Gatchalian, Ilse Dieussaert & Lode Schuerman. (2009) The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity. Pediatric Infectious Disease Journal 28:4, pages S89-S96.
Crossref
Crossref